An important step in initiating a high-throughput screening project is selecting the small molecule library to be screened against the target of interest. Many biotech companies often rely on partners or contract research organizations (CROs) to not only supply the library but also support drug discovery by performing the screen using various high-throughput assay methodologies. Choosing the best combination of a library and CRO is a critical decision that can make or break any drug discovery effort.

Learn how SAMDI Tech identified a company’s challenges with their target and designed a high-throughput binding assay by pairing the right small molecule library with a novel screening approach providing a comprehensive data package that enabled the company to make key decisions with confidence.



Download Case Study